Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Whether it's the wear-and-tear of arthritis, high blood pressure or depression, seniors often have multiple age-related health conditions and, as a result, are on multiple medications. In fact, nearly ...